Pharmacogenomic and Personalized Approaches to Tackle Nonalcoholic Fatty Liver Disease

Pharmacogenomics - United Kingdom
doi 10.2217/pgs-2016-0047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis

Journal of Clinical and Experimental Hepatology
Hepatology
2015English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Ethnicity and Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2012English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

Nonalcoholic Fatty Liver Disease in 2020

Gastroenterology
HepatologyGastroenterology
2020English

Nonalcoholic Fatty Liver Disease and Colorectal Neoplasia

Gastroenterology
HepatologyGastroenterology
2017English

Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Clinics in Liver Disease
Hepatology
2018English

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy